Acceleron Prices 3.75M Share Offering @$40.00/Share

Loading...
Loading...
Acceleron Pharma Inc.
XLRN
today announced that it has priced an underwritten public offering of 3,750,000 shares of common stock at a price to the public of $40.00 per share for gross proceeds of $150 million. In connection with this offering, Acceleron has granted the underwriters a 30-day option to purchase up to an additional 562,500 shares of common stock. Morgan Stanley, Leerink Partners LLC and UBS Investment Bank are acting as joint book-running managers for the offering. JMP Securities is acting as the lead manager and FBR is acting as co-manager for the
See full press release
Market News and Data brought to you by Benzinga APIs
Posted In: NewsOfferingsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...